SANGAMO THERAPEUTICS, INC (SGMO) Net Income (Loss) Attributable to Parent USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Sangamo Therapeutics, Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2024.
  • Sangamo Therapeutics, Inc Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$49.1 M, a 332% decline year-over-year.
  • Sangamo Therapeutics, Inc Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$328 M, a 158% decline year-over-year.
  • Sangamo Therapeutics, Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$258 M, a 34.1% decline from 2022.
  • Sangamo Therapeutics, Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$192 M, a 7.85% decline from 2021.
  • Sangamo Therapeutics, Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$178 M, a 47.3% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$328 M -$49.1 M -$70.2 M -332% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$258 M -$60.3 M -$8.32 M -16% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 -$250 M -$104 M -$51 M -96% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 -$199 M -$115 M -$71.3 M -165% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 -$127 M $21.1 M +$65.1 M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$192 M -$52 M -$14.5 M -38.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 -$178 M -$53.2 M -$5.47 M -11.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 -$172 M -$43.2 M +$4 M +8.47% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$176 M -$44 M +$1.96 M +4.26% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$178 M -$37.5 M +$3.11 M +7.65% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-13
Q3 2021 -$181 M -$47.7 M -$46.1 M -2977% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-04
Q2 2021 -$135 M -$47.2 M -$11.2 M -31.3% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-05
Q1 2021 -$124 M -$45.9 M -$3.02 M -7.04% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$121 M -$40.6 M -$45.2 M -991% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-24
Q3 2020 -$75.8 M -$1.55 M +$25.8 M +94.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$102 M -$35.9 M -$5.65 M -18.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$95.9 M -$42.9 M -$763 K -1.81% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 -$95.2 M $4.56 M +$23.2 M Oct 1, 2019 Dec 31, 2019 10-K 2021-02-24
Q3 2019 -$118 M -$27.3 M -$14.5 M -113% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-24
Q2 2019 -$104 M -$30.3 M -$13.6 M -82% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-24
Q1 2019 -$90.3 M -$42.2 M -$22 M -109% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-24
Q4 2018 -$68.3 M -$18.7 M -$5.57 M -42.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-28
Q3 2018 -$62.8 M -$12.8 M -$489 K -3.96% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-28
Q2 2018 -$62.3 M -$16.6 M -$4.15 M -33.2% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-28
Q1 2018 -$58.1 M -$20.2 M -$3.56 M -21.4% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-28
Q4 2017 -$54.6 M -$13.1 M -$3.47 M -36% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-01
Q3 2017 -$51.1 M -$12.4 M +$6.61 M +34.9% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-01
Q2 2017 -$57.7 M -$12.5 M +$14.1 M +53% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-01
Q1 2017 -$71.8 M -$16.6 M -$138 K -0.84% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-01
Q4 2016 -$71.7 M -$9.62 M +$4.39 M +31.3% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 -$76 M -$19 M -$9.72 M -105% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-01
Q2 2016 -$66.3 M -$26.6 M -$14.4 M -119% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-01
Q1 2016 -$51.9 M -$16.5 M -$11.2 M -210% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-01
Q4 2015 -$40.7 M -$14 M -$9.69 M -224% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-28
Q3 2015 -$31 M -$9.25 M -$1.7 M -22.5% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-28
Q2 2015 -$29.3 M -$12.1 M -$5.15 M -73.7% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-28
Q1 2015 -$24.2 M -$5.32 M +$2.25 M +29.8% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-28
Q4 2014 -$26.4 M -$4.32 M +$3.83 M +47% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-18
Q3 2014 -$30.2 M -$7.55 M -$1.4 M -22.8% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-18
Q2 2014 -$28.8 M -$6.98 M -$1.53 M -28.1% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-18
Q1 2014 -$27.3 M -$7.57 M -$687 K -9.98% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-18
Q4 2013 -$26.6 M -$8.14 M -$4.67 M -134% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-25
Q3 2013 -$22 M -$6.15 M -$355 K -6.13% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-25
Q2 2013 -$21.6 M -$5.45 M +$278 K +4.85% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-25
Q1 2013 -$21.9 M -$6.89 M +$383 K +5.27% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-25
Q4 2012 -$22.3 M -$3.48 M +$2.88 M +45.3% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-24
Q3 2012 -$25.1 M -$5.79 M +$3.76 M +39.4% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-24
Q2 2012 -$28.9 M -$5.73 M +$4.53 M +44.2% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-24
Q1 2012 -$33.4 M -$7.27 M +$2.31 M +24.1% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-24
Q4 2011 -$35.8 M -$6.36 M Oct 1, 2011 Dec 31, 2011 10-K 2013-02-26
Q3 2011 -$9.55 M -$859 K -9.88% Jul 1, 2011 Sep 30, 2011 10-K 2013-02-26
Q2 2011 -$10.3 M -$6.4 M -166% Apr 1, 2011 Jun 30, 2011 10-K 2013-02-26
Q1 2011 -$9.58 M Jan 1, 2011 Mar 31, 2011 10-K 2013-02-26
Q3 2010 -$8.7 M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 -$3.86 M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.